What is the maximum single dose of levetiracetam (Keppra) in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Single Dose of Levetiracetam (Keppra) in Children

The maximum single dose of levetiracetam in children for status epilepticus is 50 mg/kg IV (maximum 2500 mg) administered over 10-15 minutes. 1

Dosing Guidelines by Indication

Status Epilepticus

  • Loading dose: 30-50 mg/kg IV administered over 10-15 minutes 1
  • Maximum single dose: 50 mg/kg (not to exceed 2500 mg) 2

Maintenance Therapy

  • Initial daily dose: 20 mg/kg/day divided into two doses (10 mg/kg twice daily) 3
  • Titration: Increase by 20 mg/kg/day every 2 weeks 3
  • Recommended maintenance dose: 60 mg/kg/day divided into two doses (30 mg/kg twice daily) 3
  • Maximum FDA-approved daily dose: 60 mg/kg/day 3

Weight-Based Dosing Guide

For children weighing:

  • ≤20 kg: Use oral solution
  • 20.1-40 kg:
    • Starting: 500 mg/day (250 mg twice daily)
    • Maximum: 1500 mg/day (750 mg twice daily)
  • 40 kg:

    • Starting: 1000 mg/day (500 mg twice daily)
    • Maximum: 3000 mg/day (1500 mg twice daily) 3

Special Considerations

Higher Doses in Refractory Cases

Some children with refractory epilepsy may benefit from and tolerate doses higher than the standard 60 mg/kg/day. A study found that doses up to 275 mg/kg/day (median 146 mg/kg/day) were used in selected cases with 44% of patients showing >50% seizure reduction and only 12% experiencing adverse effects 4.

Age-Related Pharmacokinetics

  • Children have approximately 30-40% higher clearance of levetiracetam compared to adults 5
  • Half-life in children: 6.0 ± 1.1 hours (vs. longer in adults) 5
  • This may necessitate relatively higher weight-based dosing in children compared to adults

Adverse Effects

  • Most common: somnolence (10.5-15.2%), fatigue, dizziness, and irritability 1
  • Behavioral side effects (irritability, agitation) occur in approximately 12-15% of patients 1, 6
  • Higher risk in patients with intellectual disability or psychiatric history 1

Practical Recommendations

  1. For routine epilepsy management:

    • Start with 10 mg/kg twice daily
    • Titrate up by 10-20 mg/kg/day increments every 2 weeks
    • Standard target: 60 mg/kg/day in two divided doses
  2. For status epilepticus:

    • Use loading dose of 50 mg/kg IV (maximum 2500 mg) over 10-15 minutes
    • Monitor for respiratory depression when combined with other sedative agents
  3. For special situations (e.g., busulfan-induced seizure prophylaxis):

    • 10 mg/kg twice daily (20 mg/kg/day in 2 divided doses) 7

While some studies have explored much higher doses (up to 275 mg/kg/day) in refractory cases, these should be considered exceptional rather than routine practice, and require careful monitoring for adverse effects.

References

Guideline

Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Optimal regimen of levetiracetam for prevention of busulfan-induced seizure in patients undergoing hematopoietic stem cell transplantation: A review of available evidence.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.